Shopping Cart
Remove All
Your shopping cart is currently empty
Bevifimod (PRTX-100), a highly purified variant of Staphylococcal protein A (SpA), is utilized in research on idiopathic thrombocytopenic purpura (ITP) [1] [2].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Backorder | Backorder | |
| 5 mg | Inquiry | Backorder | Backorder |
| Description | Bevifimod (PRTX-100), a highly purified variant of Staphylococcal protein A (SpA), is utilized in research on idiopathic thrombocytopenic purpura (ITP) [1] [2]. |
| In vitro | Bevifimod (PRTX-100; concentrations of 250, 25, and 2.5 ng/mL; 48-hour exposure) inhibits the phagocytosis of W632-conditioned platelets by human monocytes in peripheral blood mononuclear cells (PBMC) [1]. |
| In vivo | Bevifimod (PRTX-100; 2.5-250 µg/kg; i.v.; biweekly over 4 weeks) normalizes platelet counts within 1-2 weeks with no mortality in mice [2]. |
| Synonyms | PRTX-100 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2223113-32-2 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.